Supporting Patient Safety Day

World Patient Safety Day was established in 2019 by the World Health Organization, to enhance the global understanding of patient safety, increase public engagement in the safety of health care, promote global actions and reduce patient harm.1

 

At Bayer, we take great pride in always putting patient safety and well-being first, ahead of everything else. It is at the core of all that we do and more than just an obligation. That’s why we are proud to have supported World Patient Safety Day since 2019, developing various tools and supportive materials to educate and inform the public about patient safety.

2022

Living with Heart Failure

Heart Failure (HF) is a clinical syndrome characterized by a group of symptoms that result from the inability of the heart to pump blood at a rate sufficient to meet the metabolic demands of the body. It can be a challenge on two main fronts – Identifying symptoms of worsening Heart Failure and managing the side effects of multiple medications.

 

Despite periods of stabilization, 1 in 6 patients with symptomatic Heart Failure develop worsening Heart Failure within 18 months of diagnosis.2 Symptoms that suggest the development of progressively escalating Heart Failure are easily overlooked. This poses risks because these patients require therapy intensification or hospitalization. If left unchecked, it may increase the risk of mortality.3

 

In addition, studies have shown that ~90% of older Heart Failure patients have at least three other medical conditions4 that often require five or more medications, termed “polypharmacy”.5 Side effects can occur from Heart Failure medications, or from taking multiple medications at the same time. If not adequately managed, side effects can affect the quality of life and adherence to medications.

 

Patient Safety Day 2022 aims to raise awareness to patients on the symptoms and medications for Heart Failure. We aim to educate and empower patients to identify Heart Failure symptoms and manage side effects arising from polypharmacy. These would enable them to gain the most health benefits and improve medication adherence.

 

For further information, please click on the materials below:

 

Infographics

Signs and symptoms of worsening Heart Failure or decompensation 

Alt tag
Download


Side effects of Heart Failure medications & managing polypharmacy in Heart Failure 

Alt tag
Download


Living with Heart Failure - Pamphlet version of infographic 1 & 2 

Alt tag
Download


Videos

 

A glimpse in the life of a patient with worsening Heart Failure

Detecting and managing worsening heart failure
Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.


 

Signs of worsening Heart Failure

Click below to watch an instructional video, created by Bayer, that shares tips and techniques for identifying and managing worsening Heart Failure:

 

Detecting and managing worsening heart failure
Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.


 

Common side effects of Heart Failure medications

Click below to watch an instructional video, created by Bayer, on the management and monitoring of side effects of Heart Failure drugs:

 

Side Effects of Heart Failure Medication
Author/Uploaded by

 

Polypharmacy among Heart Failure patients and how to manage it

Click below to watch an instructive video, created by Bayer, on the management of polypharmacy in Heart Failure:

 

Managing Polypharmacy in Heart Failure
Author/Uploaded by

References

  • WHO. World Patient Safety Day 2021. Available from: https://www.who.int/news-room/events/detail/2021/09/17/default-calendar/world-patient-safety-day-2021. Last accessed: August 2021. Return to content
  • Butler J et al. J Am Coll Cardiol. 2019;73:935–944; 2. Greene SJ et al. JAMA Cardiol. 2018;3:252–259; 3. EMA. CPMP/EWP/235/95, Rev.2. Accessed July 2020; Return to content
  • MacDonald M et al. J Am Heart Assoc. 2020;9:e012199; 5. Urbich M et al. PharmacoEconomics. 2020; 6. Cook C et al. Int J Cardiol. 2014;171:368–376. Return to content
  • Ozan Unlu. Circulation: Heart Failure. Polypharmacy in Older Adults Hospitalized for Heart Failure, Volume: 13, Issue: 11, DOI: (10.1161/CIRCHEARTFAILURE.120.006977). Return to content
  • Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review [published online ahead of print, 2021 Jul 2] [published correction appears in Heart Fail Rev. 2021 Jul 31;:]. Heart Fail Rev. 2021;1-28. Return to content

MA-M_VER-SG-0043-1 (03/22)

Date of preparation: 03/2022